Search query: telomeres, telomere, telomerase, TERT
The hplusroadmap IRC logs provide extensive discussion on telomeres, telomerase (TERT), and telomere length extension as central mechanisms in aging, primarily driven by user biluhuang_09127 (Bilu Huang), who advocates the TRCS model (Telomere DNA and Ribosomal DNA Co-regulation model for Cellular Senescence). Key claims include: telomere/rDNA shortening drives p53 upregulation, causing replicative senescence in adult stem cells and organismal aging; experimental telomere extension (e.g., via mRNA-TERT, AAV-TERT) increases cell divisions, reduces senescence markers (e.g., β-galactosidase), improves healthspan, and extends mouse lifespan (up to +27% maximum, +24% median) without elevating cancer risk in adults. Cancer cells often have shorter telomeres; immortality stems from p53 mutations, not telomerase. Lifespan correlates with telomere shortening rate, not initial length (e.g., mice: 6,420 bp/year, 2.5–3y lifespan; humans: 70 bp/year, 75–85y). Misconceptions (e.g., telomere extension causes cancer) are refuted. Speculations include inducible TERT with negative feedback, germline engineering, and combining with cancer suppression. Supporting evidence from 20+ papers; companies like Telocyte and T.A. Sciences mentioned. Logs refute damage-accumulation models, positioning TRCS as a “genetic program.”
This report extracts, synthesizes, and contextualizes log data for technical audiences, emphasizing causal experiments, cross-species data, and engineering speculation.
Logs emphasize causal tests: if shortening causes aging, extension should reverse it (and does).
In 2015, Stanford University scientists first used the mRNA of the telomerase catalytic subunit to increase the telomere length of skin stem cells by 0.9 kb, resulting in an increase of 28 cell replication cycles. Bodnar (1998) introduced the gene of the telomerase catalytic subunit hTERT into human retinal pigment epithelial cells and foreskin fibroblasts, finding a decrease in the content of β-galactosidase, a marker of aging, and a youthful state in the cells, while also significantly increasing cell replication cycles.
Telomeres shorten with replication (Hayflick limit); extension restores divisions and youthfulness. Not due to “unraveling” (senescent human telomeres ~half childhood length; mouse senescent > human sperm max).
Telomeres affect lifespan by their shortening rate, not their initial length. Mice transfected with TERT showed a significant increase in maximum lifespan of 27.48% and median lifespan of 16.57%.
Cross-species: shortening rate predicts lifespan (e.g., elephants: 109 bp/year, 60–70y; goats: 363 bp/year, 15y).
Cancer myth debunked: tumors have shorter telomeres (ovarian: <8 kb vs. normal 8–13 kb; liver cancer: 5.2 kb vs. normal 7.8 kb). Immortality from p53 loss.
There are many deeply entrenched misconceptions about telomeres, such as believing that lengthening telomeres causes cancer simply because tumor cells have high telomerase activity. In reality, the immortality of tumor or cancer cells is not related to telomeres, but rather to p53 gene mutations.
Extension prevents cancer: longer telomeres reduce DNA damage, boost immunity.
TRCS: Aging = telomere/rDNA shortening → ↑p53 → 11 hallmarks (e.g., mitochondrial dysfunction via PGC-1α downregulation).
The rate of aging is related to the shortening rate of telomeres and rDNA arrays which is influenced by a variety of genetic and environmental factors.
Telomeres shorten minimally in some tissues (testes, ovaries, cornea), but replication limited by other factors. Not sole “timer,” but key in stem cells.
Logs reference ~50 papers (exact/partial citations; DOIs where available). Listed chronologically/grouped:
| Year | Authors | Title/Journal | DOI/Link | Notes |
|---|---|---|---|---|
| 1996 | Urabe Y et al. | Telomere length in human liver diseases. Liver 16(5):293-297. | - | Liver cancer telomeres: 5.2 kb (normal: 7.8 kb). |
| 1998 | Egan CA et al. | Analysis of telomere lengths in human corneal endothelial cells… Investigative Ophthalmology & Visual Science 39(3):648-653. | - | Long telomeres lifelong, no telomerase. |
| 1998 | Bodnar AG et al. | Extension of life-span by introduction of telomerase into normal human cells. Science 279(5349):349-52. | 10.1126/science.279.5349.349 | hTERT → youthful state, ↑divisions. |
| 1999 | Xu Yaohong | [Review on ovarian tumors]. Foreign Medical Sciences (Geriatrics) 20(3):128. | - | Ovarian tumors: <8 kb telomeres. |
| 2012 | de Jesus BB et al. | Telomerase gene therapy in adult and old mice delays aging… EMBO Mol Med. | PubMed:22585399 | AAV-TERT: +24%/13% lifespan, no ↑cancer. |
| 2015 | Ramunas J et al. | Transient delivery of modified mRNA encoding TERT… FASEB J 29(5):1930-9. | 10.1096/fj.14-259531 | +0.9 kb, +28 divisions. |
| 2016 | Muñoz-Cánoves et al. | [Nature Communications, Jun 2]. | - | Longer telomeres → healthier mice, ↓cancer. |
| 2019 | Chew GL et al. | DUX4 Suppresses MHC Class I… Dev Cell. | 10.1016/j.devcel.2019.06.011 | Shorter telomeres ↑DUX4 → immune evasion. |
| 2020 | [Science] | Determinants of telomere length across human tissues. | science.sciencemag.org/content/369/6509/eaaz6876 | Minimal shortening in testes/ovaries. |
| 2025 | Zhu TY et al. | Telomerase reverse transcriptase gene knock-in… Aging Cell 24(4):e14445. | 10.1111/acel.14445 | +27% max lifespan. |
| - | [Various] | Telomerase-Cancer-Clock.pdf (Eli); Leukocyte telomere length… (2008); DCAF4 (2015); etc. | - | Telomere shortening as cancer clock; GWAS hits. |
Full list in logs includes: Mangino 2015 (DCAF4); TRF1 gene therapy (2017); etc. (see context for exhaustive extraction).
Logs speculate on “weird ideas” → innovations:
even with inducible TERT expression… ideally we’d have inducible telomerase but with some negative feedback… i found this paper… even with increased TERT you can also increase p53 and the combination still results in extended lifespan.
Brainstorm: Feedback-loop TERT (sensor: telomere-binding proteins → promoter); orthogonal stem cell replacement (no telomerase, periodic refresh); rDNA synthetic arrays (error-corrected, MHz recombinases).
Logs robustly support telomere maintenance (esp. TERT) as viable longevity intervention, with causal evidence trumping correlations. TRCS unifies hallmarks under p53 clock; extension outperforms alternatives (e.g., rapamycin inhibits proliferation → side effects). Prime for engineering: germline/AAV TERT + feedback/cancer safeguards. Prioritize primate trials, rDNA integration. Esoteric: Predation-proof “warranty” genes for negligible senescence.
For full logs/transcripts: diyhpl.us transcripts (e.g., bilu-huang-2025). Further reading: Bilu Huang’s SSRN/aging.biluhuang.com.